Literature DB >> 2180826

Identification of a pathogenic isolate-specific 30,000-Mr antigen of Entamoeba histolytica by using a monoclonal antibody.

H Tachibana1, S Kobayashi, Y Kato, K Nagakura, Y Kaneda, T Takeuchi.   

Abstract

A monoclonal antibody (MAb) produced against trophozoites of Entamoeba histolytica strain HM-1:IMSS, reacted with all of 42 isolates and 4 clones showing pathogenic zymodeme (Z) patterns, i.e., Z-II, Z-II alpha-, Z-II (glucose phosphate isomerase: gamma +), Z-VII, Z-VII (glucose phosphate isomerase: alpha lack, gamma +), Z-XI, Z-XIV, and Z-XIX, regardless of culture conditions, geographical origins, or host symptoms in an indirect fluorescence antibody test. In contrast, the MAb failed to react with 14 isolates possessing nonpathogenic zymodemes Z-I and Z-VIII and did not react with other enteric protozoan parasites, such as E. histolytica-like Laredo, Entamoeba hartmanni, Entamoeba coli, Endolimax nana, Dientamoeba fragilis, Trichomonas hominis, and Giardia lamblia. Western immunoblotting analysis showed that the molecular weight of the antigenic component recognized by the MAb was exclusively 30,000 in pathogenic isolates of different zymodemes. These results suggest that the 30,000-molecular-weight antigen is a marker of pathogenic isolates and that the indirect fluorescent-antibody test with the MAb is useful for the accurate discrimination of pathogenic amebae.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180826      PMCID: PMC258567          DOI: 10.1128/iai.58.4.955-960.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Effect of culture conditions and bacterial associates on the zymodemes of Entamoeba histolytica.

Authors:  D Mirelman
Journal:  Parasitol Today       Date:  1987-02

2.  A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba.

Authors:  L S Diamond; D R Harlow; C C Cunnick
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  The laboratory diagnosis of human parasitic amoebae.

Authors:  G L Robinson
Journal:  Trans R Soc Trop Med Hyg       Date:  1968       Impact factor: 2.184

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Differences in adhesion, phagocytosis and virulence of clones from Entamoeba histolytica, strain HM1:IMSS.

Authors:  E Orozco; M E Suárez; T Sánchez
Journal:  Int J Parasitol       Date:  1985-12       Impact factor: 3.981

7.  Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented with bile.

Authors:  D B Keister
Journal:  Trans R Soc Trop Med Hyg       Date:  1983       Impact factor: 2.184

8.  DNA probes specific for Entamoeba histolytica possessing pathogenic and nonpathogenic zymodemes.

Authors:  L I Garfinkel; M Giladi; M Huber; C Gitler; D Mirelman; M Revel; S Rozenblatt
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

9.  Entamoeba histolytica: effect of growth conditions and bacterial associates on isoenzyme patterns and virulence.

Authors:  D Mirelman; R Bracha; A Chayen; A Aust-Kettis; L S Diamond
Journal:  Exp Parasitol       Date:  1986-08       Impact factor: 2.011

10.  Characterization of a membrane pore-forming protein from Entamoeba histolytica.

Authors:  J D Young; T M Young; L P Lu; J C Unkeless; Z A Cohn
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

View more
  30 in total

1.  Preparation of a monoclonal antibody specific for Entamoeba dispar and its ability to distinguish E. dispar from E. histolytica.

Authors:  H Tachibana; S Kobayashi; Y Kaneda; T Takeuchi; T Fujiwara
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  Preparation of recombinant human monoclonal antibody Fab fragments specific for Entamoeba histolytica.

Authors:  H Tachibana; X J Cheng; K Watanabe; M Takekoshi; F Maeda; S Aotsuka; Y Kaneda; T Takeuchi; S Ihara
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

Review 3.  Progress towards development of a vaccine for amebiasis.

Authors:  S L Stanley
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

4.  Entamoeba histolytica and Entamoeba dispar infections in cynomolgus monkeys imported into Japan for research.

Authors:  Jun-ichiro Takano; Toyoko Narita; Hiroshi Tachibana; Toshiyuki Shimizu; Hirofumi Komatsubara; Keiji Terao; Koji Fujimoto
Journal:  Parasitol Res       Date:  2005-07-01       Impact factor: 2.289

5.  An integrated microfluidic device for rapid serodiagnosis of amebiasis.

Authors:  Wang Zhao; Li Zhang; Wenwen Jing; Sixiu Liu; Hiroshi Tachibana; Xunjia Cheng; Guodong Sui
Journal:  Biomicrofluidics       Date:  2013-02-21       Impact factor: 2.800

6.  Pathogenicity of Entamoeba histolytica isolates from Shanghai, China.

Authors:  X J Cheng; H Tachibana; S Kobayashi; Y Kaneda; M Y Huang
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

7.  Differences in genomic DNA sequences between pathogenic and nonpathogenic isolates of Entamoeba histolytica identified by polymerase chain reaction.

Authors:  H Tachibana; S Ihara; S Kobayashi; Y Kaneda; T Takeuchi; Y Watanabe
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

Review 8.  Host-pathogen interaction in amebiasis and progress in vaccine development.

Authors:  C D Huston; W A Petri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

9.  Entamoeba histolytica and E. dispar infections in captive macaques (Macaca fascicularis) in the Philippines.

Authors:  Windell L Rivera; John Anthony D L Yason; Davin Edric V Adao
Journal:  Primates       Date:  2009-10-28       Impact factor: 2.163

10.  VH3 gene usage in neutralizing human antibodies specific for the Entamoeba histolytica Gal/GalNAc lectin heavy subunit.

Authors:  Hiroshi Tachibana; Katsuomi Watanabe; Xun-Jia Cheng; Hideo Tsukamoto; Yoshimasa Kaneda; Tsutomu Takeuchi; Seiji Ihara; William A Petri
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.